tele.clinic
Start my intake

Free questionnaire · Not prescribed? You’re not charged.

Vial of compounded tirzepatideWeight Loss

Compounded Tirzepatide

Physician-prescribed compounded tirzepatide with dual GIP/GLP-1 action.

Vial strengthper 2 mL vial

Your provider will select the appropriate dosing for you.

Price includes everything: consultation, medication, shipping and ongoing support.

Start my intake

Free questionnaire · takes about 10 minutes. Not prescribed? You’re not charged. Your physician confirms your dose.

  • Same price at every dose
  • No insurance required
  • No hidden fees
  • Ongoing clinical support

Intro pricing — your rate is locked for the life of your membership

  • Average 20–22% reduction in body weight in clinical trials
  • Dual mechanism targeting two separate hormone pathways
  • Stronger appetite suppression than single-agent GLP-1 therapy
See all clinical benefits →

HIPAA-compliant · Licensed in 47 states

Board-certified physiciansMD/DO, licensed in your state
Licensed 503A pharmacyCompounded by Rush Pharmacy
HIPAA-secureEncrypted, private records
Free discreet shippingTracked, temperature-safe

How it works

Three steps to your first shipment

01

Free online questionnaire

Answer questions about your health history and goals. Takes about 10 minutes — no appointment needed.

02

Physician review

A licensed US physician reviews your case and confirms whether you're a candidate within 24–48 hours.

03

Free discreet delivery

Your medication is compounded by a licensed US pharmacy and shipped to your door at no extra cost.

Overview

What is Tirzepatide?

Compounded tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. As the first of its class, tirzepatide activates two separate hormone pathways simultaneously, resulting in superior weight loss compared to GLP-1 monotherapy. Clinical trials (SURMOUNT-1) demonstrated average weight loss of 20–22% body weight — the highest ever recorded in a pharmaceutical weight-loss trial.

Mechanism of action

How it works

Tirzepatide activates both GIP and GLP-1 receptors. GLP-1 activation suppresses appetite and slows digestion; GIP activation further enhances insulin sensitivity and may directly affect fat storage in adipose tissue. The combined dual-receptor agonism produces synergistic weight loss effects that exceed those of GLP-1 agents alone.

Clinical benefits

What patients experience

Average 20–22% reduction in body weight in clinical trials

Dual mechanism targeting two separate hormone pathways

Stronger appetite suppression than single-agent GLP-1 therapy

Significant improvement in blood sugar and insulin sensitivity

Favorable cardiovascular risk profile

Once-weekly subcutaneous injection

Start my intake

Free intake questionnaire · Physician review within 24–48 hours

Safety information

Potential side effects

  • Nausea (most common, especially when titrating up)
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Decreased appetite
  • Rare: pancreatitis, gallbladder disease

Who should not use this

Contraindications

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Pregnancy or breastfeeding
  • Hypersensitivity to tirzepatide
  • Severe GI motility disorders

This list is not exhaustive. A licensed physician will review your complete medical history before prescribing. Do not self-prescribe.

Common questions

About Tirzepatide

Ready to start your Tirzepatide program?

Complete a free intake questionnaire. A licensed physician will review your case and respond within 24–48 hours.

Start my intake

$149 billed monthly · 5mg to start. Cancel anytime.

Licensed US physicians · Licensed compounding pharmacy · HIPAA-secure · Available in 47 states